Lumonus and Smarter Radiation Oncology Partner to Enhance Cancer Treatment
Lumonus has announced a transformative multi-year licensing agreement with Smarter Radiation Oncology (SRO), announced in a press release. This collaboration aims to advance the delivery of standardized radiation therapy by integrating SRO's evidence-based treatment protocols into Lumonus' AI-powered platform.
SRO, developed at Northwell Health, has systematized nearly 90% of radiation therapy treatments across its cancer centers, setting clear prescribing standards and improving safety and efficiency. By embedding these directives into the Lumonus AI Physician platform, clinicians will have access to validated prescribing standards at the point of care, facilitating faster and more consistent treatment decisions.
The partnership is expected to enhance the quality and consistency of radiation oncology care, making these standards available to cancer centers worldwide. This integration supports Lumonus' mission to simplify oncology workflows by automating administrative tasks, ultimately helping physicians deliver safer and more efficient care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Linearis Joins Two Canadian AI Health Data Projects
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Suvoda Updates Clinical Trial Platform With AI and Unified Access
Daily AI Brief: the AI news that matters, in your inbox.